Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A local establishment was awarded more than $70,000 in grants in connection to some innovation development projects.

ELMSFORD, N.Y. - NanoVibronix , Inc. (NASDAQ:NAOV), a medical device company with a current market capitalization of $2.25 million, has announced the acquisition of ENvue Medical (TASE:PMCN) Holdings ...

Start-up accelerators are designed to rapidly scale early-stage companies through mentorship, funding and resources.

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

BRAIN Biotech is contributing its proprietary bioleaching technology as the core technology for recovering of BioGold TM. The PX Urban Mining Initiative is open to additional partners who wish to ...

The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...